BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lyra-González I, Flores-Fong LE, González-García I, Medina-Preciado D, Armendáriz-Borunda J. MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine. World J Hepatol 2015; 7(11): 1530-1540 [PMID: 26085912 DOI: 10.4254/wjh.v7.i11.1530]
URL: https://www.wjgnet.com/1948-5182/full/v7/i11/1530.htm
Number Citing Articles
1
Yujing Wu, Shuang Liu, Zhijuan Fan, Yaqiong Tian, Lei Zhang, Shuye Liu. Establishment and Validation of a Blood Test-based Nomogram to Diagnose Patients with AFP-negative HCCCurrent Cancer Drug Targets 2024; 24(5): 556 doi: 10.2174/0115680096264770231113103930
2
Agnieszka Piechowska, Celina Kruszniewska-Rajs, Magdalena Kimsa-Dudek, Magdalena Kołomańska, Barbara Strzałka-Mrozik, Joanna Gola, Stanisław Głuszek. The role of miR-370 and miR-138 in the regulation of BMP2 suppressor gene expression in colorectal cancer: preliminary studiesJournal of Cancer Research and Clinical Oncology 2022; 148(7): 1569 doi: 10.1007/s00432-022-03977-4
3
Xue-Min Wu, Zhi-Feng Xi, Pinhu Liao, Hong-Dong Huang, Xiao-Ying Huang, Chao Wang, Yun Ma, Qiang Xia, Jin-Guang Yao, Xi-Dai Long. Diagnostic and prognostic potential of serum microRNA-4651 for patients with hepatocellular carcinoma related to aflatoxin B1Oncotarget 2017; 8(46): 81235 doi: 10.18632/oncotarget.16027
4
Peipei Hao, Fengming Yue, Xian Xian, Qian Ren, Huixian Cui, Yunpeng Wang. Inhibiting effect of MicroRNA-3619-5p/PSMD10 axis on liver cancer cell growth in vivo and in vitroLife Sciences 2020; 254: 117632 doi: 10.1016/j.lfs.2020.117632
5
Bin Sun, Weidan Ji, Chunying Liu, Xuejing Lin, Lei Chen, Haihua Qian, Changqing Su. miR‐2392 functions as tumour suppressor and inhibits malignant progression of hepatocellular carcinoma via directly targeting JAG2Liver International 2022; 42(7): 1658 doi: 10.1111/liv.15284
6
Mascha Korsch, Alexander Margetts, Claes Wahlestedt, Ines Lohse. Non-Coding RNAs in Hepatocellular CarcinomaLivers 2022; 2(3): 185 doi: 10.3390/livers2030017
7
Juan Cristina, Ricardo Recarey. Identification of MicroRNA-Like Molecules Derived from the Antigenome RNA of Hepatitis C Virus: A Bioinformatics ApproachNatural Science 2016; 8(04): 180 doi: 10.4236/ns.2016.84021
8
Peng Li, Qingmin Li, Yanqiang Zhang, Shaojun Sun, Shuntao Liu, Zhaoxi Lu. MiR-422a targets MAPKK6 and regulates cell growth and apoptosis in colorectal cancer cellsBiomedicine & Pharmacotherapy 2018; 104: 832 doi: 10.1016/j.biopha.2018.03.013
9
Guangbin Jiang, Li Wen, Weiping Deng, Zhiyuan Jian, Hongmei Zheng. Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2Biomedicine & Pharmacotherapy 2017; 90: 806 doi: 10.1016/j.biopha.2017.03.081
10
Jaihwan Kim, Ji Kon Ryu, Sang Hyub Lee, Yong-Tae Kim. MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract CancersGut and Liver 2016; 10(5): 836 doi: 10.5009/gnl15460
11
Hong-Bin Jiao, Wei Wang, Meng-Nan Guo, Ya-Li Su, De-Quan Pang, Bao-Lin Wang, Jun Shi, Jing-Hua Wu. Evaluation of high-risk factors and the diagnostic value of alpha-fetoprotein in the stratification of primary liver cancerWorld Journal of Clinical Cases 2022; 10(26): 9264-9275 doi: 10.12998/wjcc.v10.i26.9264
12
HAIFEI HE, WEI TIAN, HAILONG CHEN, YONGCHUAN DENG. MicroRNA-101 sensitizes hepatocellular carcinoma cells to doxorubicin-induced apoptosis via targeting Mcl-1Molecular Medicine Reports 2016; 13(2): 1923 doi: 10.3892/mmr.2015.4727
13
Ping Luo, Sanyun Wu, Yalan Yu, Xinliang Ming, Shuo Li, Xuelan Zuo, Jiancheng Tu. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier StagePathology & Oncology Research 2020; 26(2): 599 doi: 10.1007/s12253-019-00585-5
14
Li Huang, Zhuning Mo, Zuojian Hu, Linyan Zhang, Shanzi Qin, Xue Qin, Shan Li. Diagnostic value of fibrinogen to prealbumin ratio and gamma-glutamyl transpeptidase to platelet ratio in the progression of AFP-negative hepatocellular carcinomaCancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-1161-y
15
Ke Jin, Tong Li, Gonzalo Sánchez-Duffhues, Fangfang Zhou, Long Zhang. Involvement of inflammation and its related microRNAs in hepatocellular carcinomaOncotarget 2017; 8(13): 22145 doi: 10.18632/oncotarget.13530
16
Guangbin Jiang, Li Wen, Hongmei Zheng, Zhiyuan Jian, Weiping Deng. miR‐204‐5p targeting SIRT1 regulates hepatocellular carcinoma progressionCell Biochemistry and Function 2016; 34(7): 505 doi: 10.1002/cbf.3223
17
Guanyu Zhang, Yiran Li, Jiasheng Xu, Zhenfang Xiong. Advances in the role of miRNAs in the occurrence and development of osteosarcomaOpen Medicine 2020; 15(1): 1003 doi: 10.1515/med-2020-0205
18
Gui-Xi Zheng, Ai-Lin Qu, Yong-Mei Yang, Xin Zhang, Shou-Cai Zhang, Chuan-Xin Wang. miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancerWorld Journal of Gastroenterology 2016; 22(24): 5589-5597 doi: 10.3748/wjg.v22.i24.5589
19
Pingping Dong, Xiaoxiao Wang, Longzi Liu, Wenqing Tang, Lijie Ma, Wenjiao Zeng, Shaoyang Sun, Li Zhang, Ningping Zhang, Xizhong Shen, Harry L.A. Janssen, Ling Dong, Si Zhang, She Chen. Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinomaJournal of Hepatology 2020; 73(6): 1446 doi: 10.1016/j.jhep.2020.06.027
20
Xi-Dai Long, Wei-Zhong Tang, Jun Lu, Xiao-Ying Huang, Jin-Guang Yao, Tian-Qi Zhang, Xing-Zhizi Wang, Qun-Ying Su, Chun-Ying Luo, Xue-Ming Wu, Chao Wang, Li-Xia Zeng, Qiang Xia, Yun Ma. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment2018;  doi: 10.5772/intechopen.72276
21
Kashif Rafiq Zahid, Mingyang Su, Abdur Rehman Raza Khan, Shiming Han, Gou Deming, Umar Raza. Systems biology based meth-miRNA–mRNA regulatory network identifies metabolic imbalance and hyperactive cell cycle signaling involved in hepatocellular carcinoma onset and progressionCancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0804-3
22
J Huang, J Yang, Y Lei, H Gao, T Wei, L Luo, F Zhang, H Chen, Q Zeng, L Guo. An ANCCA/PRO2000-miR-520a-E2F2 regulatory loop as a driving force for the development of hepatocellular carcinomaOncogenesis 2016; 5(5): e229 doi: 10.1038/oncsis.2016.22
23
Daniela Campion, Alessandra Tucci, Paola Ponzo, Gian Paolo Caviglia. Non-invasive biomarkers for the detection of hepatocellular carcinomaMinerva Biotecnologica 2019; 31(1) doi: 10.23736/S1120-4826.18.02488-6
24
Ming-De Yan, Chih-Jung Yao, Jyh-Ming Chow, Chia-Lun Chang, Pai-An Hwang, Shuang-En Chuang, Jacqueline Whang-Peng, Gi-Ming Lai. Fucoidan Elevates MicroRNA-29b to Regulate DNMT3B-MTSS1 Axis and Inhibit EMT in Human Hepatocellular Carcinoma CellsMarine Drugs 2015; 13(10): 6099 doi: 10.3390/md13106099
25
Yanping Wei, Rongquan He, Yuzhuang Wu, Binliang Gan, Peirong Wu, Xiaohui Qiu, Aihua Lan, Gang Chen, Qiuyan Wang, Xinggu Lin, Yingchun Chen, Zengnan Mo. Comprehensive investigation of aberrant microRNA profiling in bladder cancer tissuesTumor Biology 2016; 37(9): 12555 doi: 10.1007/s13277-016-5121-z